AMEND has developed a patient questionnaire for people with multiple endocrine neoplasia disorders (GenNETs) who HAVE HAD Coronavirus. The survey can be completed by patients who have recovered, or by relatives or health professionals for anyone who may sadly have died. AMEND is making the question file available to anyone on request, so that you can set up a similar survey in your own country.

Please contact AMEND CEO, Jo Grey ( for more information.